ASTM F1635-04 - 1.5.2004
 
1. Scope

1.1 This test method covers in vitro degradation of hydrolytically degradable polymers (HDP) intended for use in surgical implants.

1.2 The requirements of this test method apply to HDPs in various forms:

1.2.1 Virgin polymer resins, or

1.2.2 Any form fabricated from virgin polymer such as a semi-finished component of a finished product, a finished product, which may include packaged and sterilized implants, or a specially fabricated test specimen.

1.3 This test method has no provisions for mechanical loading, fluid flow, or other dynamic challenges.

1.4 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory limitations prior to use.

 
2. Referenced Documents

D638-22

Standard Test Method for Tensile Properties of Plastics

D671-93

Standard Test Method for Flexural Fatigue of Plastics by Constant-Amplitude-of-Force (Withdrawn 2002)

D2857-22

Standard Practice for Dilute Solution Viscosity of Polymers

D1822-21

Standard Test Method for Determining the Tensile-Impact Resistance of Plastics

D1708-18

Standard Test Method for Tensile Properties of Plastics by Use of Microtensile Specimens

D882-18

Standard Test Method for Tensile Properties of Thin Plastic Sheeting

D790-17

Standard Test Methods for Flexural Properties of Unreinforced and Reinforced Plastics and Electrical Insulating Materials

D747-10

Standard Test Method for Apparent Bending Modulus of Plastics by Means of a Cantilever Beam (Withdrawn 2019)

D695-23

Standard Test Method for Compressive Properties of Rigid Plastics

F748-16

Standard Practice for Selecting Generic Biological Test Methods for Materials and Devices